Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test.
dc.contributor.author | Padi, Satyanarayana S V | en_US |
dc.contributor.author | Kulkarni, Shrinivas K | en_US |
dc.date.accessioned | 2009-05-28T15:50:09Z | |
dc.date.available | 2009-05-28T15:50:09Z | |
dc.date.issued | 2005-01-05 | en_US |
dc.description.abstract | Lipopolysaccharide (LPS)-induced hyperalgesia and the role of cyclooxygenase (COX) isoforms in acute and chronic nociceptive assays have been well established. However, the role of COX isoforms in LPS-induced hyperalgesia in the formalin test is not clear. Thus, the present study was undertaken to characterize the time course of formalin-induced nociceptive response in LPS-pretreated mice and to investigate possible effects of COX inhibitors to address the potential role of COX isoforms in LPS-induced hyperalgesia in the formalin test. All the animals showed typical biphasic response to formalin challenge. At 0 hr (immediately) and 4 hr after LPS pretreatment, animals did not show any alteration in formalin-induced tonic pain. However, 12 and 16 hr after LPS pretreatment, there was a significant increase in the late phase of formalin-induced nocifensive response as compared to control mice. Treatment with intravenously administered ketorolac (a nonselective COX inhibitor) significantly and dose-dependently inhibited the late phase of formalin-induced nociceptive behaviour in saline and LPS-pretreated mice. In contrast, parecoxib (prodrug of valdecoxib, a selective COX-2 inhibitor) or dexamethasone (COX-2 transcription inhibitor), when administered intravenously or intraperitoneally, respectively, did not show antinociceptive effect in the formalin test in saline-pretreated mice. However, both the agents significantly and dose-dependently decreased the late phase nociceptive behaviour of the formalin test in LPS-pretreated mice to the level of the animals that received saline pretreatment. These results suggest that induction of COX-2 by proinflammatory mediators and subsequent release of prostaglandins could be responsible for LPS enhancement of formalin-induced nocifensive behaviour and supports an important role of COX-2 in LPS-induced hyperalgesia in the formalin test. | en_US |
dc.description.affiliation | University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India. | en_US |
dc.identifier.citation | Padi SS, Kulkarni SK. Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test. Indian Journal of Experimental Biology. 2005 Jan; 43(1): 53-60 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/62474 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.niscair.res.in/ScienceCommunication/ResearchJournals/rejour/ijeb/ijeb0.asp | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Cyclooxygenase 2 | en_US |
dc.subject.mesh | Cyclooxygenase 2 Inhibitors | en_US |
dc.subject.mesh | Cyclooxygenase Inhibitors --therapeutic use | en_US |
dc.subject.mesh | Dexamethasone --therapeutic use | en_US |
dc.subject.mesh | Disease Models, Animal | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hyperalgesia --chemically induced | en_US |
dc.subject.mesh | Isoenzymes --metabolism | en_US |
dc.subject.mesh | Isoxazoles --therapeutic use | en_US |
dc.subject.mesh | Ketorolac --therapeutic use | en_US |
dc.subject.mesh | Lipopolysaccharides --toxicity | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Pain Measurement | en_US |
dc.subject.mesh | Prostaglandin-Endoperoxide Synthases --metabolism | en_US |
dc.subject.mesh | Salmonella typhimurium --metabolism | en_US |
dc.title | Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1